Search results for "Infectious diseases"


 
Results 61 - 70 of about 301 for "Infectious diseases".
Sort by: Relevance | Newest | Oldest

Resist the urge to overtreat bacteriuria

Antibiotics could be avoided more frequently even in patients who have significant bacteriuria if a physician takes the time to convey potential antibiotic risks.
https://immattersacp.org/archives/2019/07/resist-the-urge-to-overtreat-bacteriuria.htm
1 Jul 2019

ACP recognizes National Immunization Awareness Month

ACP's immunization resources include practice management tools such as webinars and videos that cover the latest vaccine recommendations, coaching calls to assist physicians in implementing standing orders, and a residency training program to help program directors identify quality improvement projects.
https://immattersacp.org/weekly/archives/2016/08/02/6.htm
2 Aug 2016

COVID-19 rebound occurs with or without antivirals, doesn't affect outcomes, studies find

Rebound of both COVID-19 symptoms and viral load was rare in untreated, unvaccinated outpatients, one study showed, while another found similar rates of viral rebound in patients treated with nirmatrelvir-ritonavir, molnupiravir, or neither antiviral.
https://immattersacp.org/weekly/archives/2023/02/21/2.htm
21 Feb 2023

Antibiotic stewardship improved prescribing for suspected UTI in frail older adults

Inappropriate antibiotic prescribing for suspected urinary tract infections (UTIs) was reduced in practices and facilities assigned to use a decision tool instead of usual care, particularly for patients with dementia, a randomized trial in Europe found.
https://immattersacp.org/weekly/archives/2023/02/28/5.htm
28 Feb 2023

Obituaries

The College notes the passing of Michael F. Rein, MD, MACP; William R. Smith, MD, MACP; Cyril (Kim) M. Hetsko, MD, MACP; and Alan Gordon, MD, MACP.
https://immattersacp.org/archives/2023/01/obituaries.htm
1 Jan 2023

Studies look at COVID-19 vaccine boosters; ACP, Annals forum tackles challenging clinical questions

Two Israeli studies showed that vaccine boosters reduced rates of infection and severe disease. Experts gathered for the seventh ACP and Annals of Internal Medicine virtual forum on COVID-19. The FDA authorized a monoclonal antibody for pre-exposure prophylaxis in certain patients.
https://immattersacp.org/weekly/archives/2021/12/14/1.htm
14 Dec 2021

Telemedicine's time has arrived

As the need for remote health care expands, medical educators and residents continue to refine the best ways to teach and learn telemedicine.
https://immattersacp.org/archives/2022/09/telemedicines-time-has-arrived.htm
1 Sep 2022

Latest COVID-19 guidelines come out against bamlanivimab, remdesivir

The NIH and the Infectious Diseases Society of America found insufficient data to support bamlanivimab, while the World Health Organization said the same about remdesivir. The FDA issued more emergency use authorizations, and research looked at racial and other disparities in COVID-19 outcomes.
https://immattersacp.org/weekly/archives/2020/11/24/1.htm
24 Nov 2020

Prepare for next pandemic by training leaders

In response to the COVID-19 pandemic and the prospect of others, public health and medical groups are developing training initiatives to increase the numbers of infectious disease and public health specialists across the country.
https://immattersacp.org/archives/2023/03/prepare-for-next-pandemic-by-training-leaders.htm
1 Mar 2023

ATS/IDSA release clinical practice guideline on diagnosing, treating CAP

The new American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) guideline updates the 2007 community-acquired pneumonia (CAP) guideline, and changes include a different perspective on macrolides.
https://immattersacp.org/weekly/archives/2019/10/08/4.htm
8 Oct 2019

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next